Bax et al. investigated the encapsulation of mannose-terminated glucocerebrosidase (Alglucerase), a licensed pharmaceutical enzyme preparation available for the treatment of Gaucher’s disease. This evidence concerns the gene GBA1 and Gaucher disease.